How many clinical trials are there for Etomidate Adverse Reaction?

PlainTrial tracks 1 US clinical trials for Etomidate Adverse Reaction, of which 1 are currently recruiting.

Which interventions appear most often on Etomidate Adverse Reaction trial records?

Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7) is the most-linked intervention name on Etomidate Adverse Reaction records (1 trial links), followed by Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Etomidate Adverse Reaction?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Etomidate Adverse Reaction: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Etomidate Adverse Reaction trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Etomidate Adverse Reaction: 1 US clinical trial tracked, 1 recruiting.

Etomidate Adverse Reaction is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Texas Southwestern Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition etomidate-adverse-reaction

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Etomidate Adverse Reaction

Etomidate Adverse Reaction lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Etomidate Adverse Reaction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Etomidate Adverse Reaction is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 3 200 participants

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

University of Texas Southwestern Medical Center

NCT05358535

Phase Distribution

Phase	Trial count
Phase 3	1

Top Sponsors

University of Texas Southwestern Medical Center 1 trials

Named interventions

Most-linked intervention names on Etomidate Adverse Reaction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7) Drug

1 trials

Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2) Drug

1 trials

US sites by state

Facility locations filed on Etomidate Adverse Reaction trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Etomidate Adverse Reaction page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Etomidate Adverse Reaction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
University of Texas Southwestern Medical Center sponsors the most Etomidate Adverse Reaction trials on record, review their full trial history before evaluating a specific study. See University of Texas Southwestern Medical Center's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Etomidate Adverse Reaction condition card totals 1 registered trials; most-linked intervention Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.